Justyna Jankowska-Sanetra, Krzysztof Sanetra, Marta Konopko, Monika Kutowicz, Magdalena Synak, Krzysztof Milewski, Paweł Kaźmierczak, Łukasz Kołtowski, Piotr P Buszman
{"title":"2019年波兰第一波SARS-CoV-2大流行对稳定型冠状动脉疾病住院患者特征和预后的影响","authors":"Justyna Jankowska-Sanetra, Krzysztof Sanetra, Marta Konopko, Monika Kutowicz, Magdalena Synak, Krzysztof Milewski, Paweł Kaźmierczak, Łukasz Kołtowski, Piotr P Buszman","doi":"10.5603/CJ.a2022.0094","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>An investigation of baseline characteristics, treatment, and outcomes in patients with stable coronary disease after the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS- -CoV-2) pandemic may provide valuable data and is beneficial for public health strategy in upcoming years.</p><p><strong>Methods: </strong>A multi-institutional registry, including 10 cardiology departments, was searched for patients admitted from June 2020 to October 2020. The baseline characteristics (age, gender, symptoms, comorbidities), treatment (non-invasive, invasive, surgical), and hospitalization outcome (mortality, myocardial infarction, stroke, composite endpoint - major adverse cardiac and cerebrovascular events [MACCE]) were evaluated. The comparison was made to parameters presented by patients from the same timeframe in 2019 (June-October). Multivariable analysis was performed.</p><p><strong>Results: </strong>Number of hospitalized stable patients following lockdown was lower (2498 vs. 1903; p < 0.0001). They were younger (68.0 vs. 69.0; p < 0.019), more likely to present with hypertension (88.5% vs. 77.5%; p < 0.0001), diabetes (35.7% vs. 31.5%; p = 0.003), hyperlipidemia (67.9% vs. 55.4%; p < 0.0001), obesity (35.8% vs. 31.3%; p = 0.002), and more pronounced symptoms (Canadian Cardiovascular Society [CCS] III and CCS class IV angina: 30.4% vs. 26.5%; p = 0.005). They underwent percutaneous treatment more often (35.0% vs. 25.9%; p < 0.0001) and were less likely to be referred for surgery (3.7% vs. 4.9%; p = 0.0001). There were no significant differences in hospitalization outcome. New York Heart Association (NYHA) class IV for heart failure was a risk factor for both mortality and MACCE in multivariate analysis.</p><p><strong>Conclusions: </strong>The SARS-CoV-2 2019 pandemic affected the characteristics and hospitalization course of stable angina patients hospitalized following the first wave. The hospitalization outcome was similar in the analyzed time intervals. The higher prevalence of comorbidities raises concern regarding upcoming years.</p>","PeriodicalId":9492,"journal":{"name":"Cardiology journal","volume":"30 3","pages":"337-343"},"PeriodicalIF":2.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/61/ed/cardj-30-3-337.PMC10287081.pdf","citationCount":"0","resultStr":"{\"title\":\"The impact of first wave of the SARS-CoV-2 2019 pandemic in Poland on characteristics and outcomes of patients hospitalized due to stable coronary artery disease.\",\"authors\":\"Justyna Jankowska-Sanetra, Krzysztof Sanetra, Marta Konopko, Monika Kutowicz, Magdalena Synak, Krzysztof Milewski, Paweł Kaźmierczak, Łukasz Kołtowski, Piotr P Buszman\",\"doi\":\"10.5603/CJ.a2022.0094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>An investigation of baseline characteristics, treatment, and outcomes in patients with stable coronary disease after the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS- -CoV-2) pandemic may provide valuable data and is beneficial for public health strategy in upcoming years.</p><p><strong>Methods: </strong>A multi-institutional registry, including 10 cardiology departments, was searched for patients admitted from June 2020 to October 2020. The baseline characteristics (age, gender, symptoms, comorbidities), treatment (non-invasive, invasive, surgical), and hospitalization outcome (mortality, myocardial infarction, stroke, composite endpoint - major adverse cardiac and cerebrovascular events [MACCE]) were evaluated. The comparison was made to parameters presented by patients from the same timeframe in 2019 (June-October). Multivariable analysis was performed.</p><p><strong>Results: </strong>Number of hospitalized stable patients following lockdown was lower (2498 vs. 1903; p < 0.0001). They were younger (68.0 vs. 69.0; p < 0.019), more likely to present with hypertension (88.5% vs. 77.5%; p < 0.0001), diabetes (35.7% vs. 31.5%; p = 0.003), hyperlipidemia (67.9% vs. 55.4%; p < 0.0001), obesity (35.8% vs. 31.3%; p = 0.002), and more pronounced symptoms (Canadian Cardiovascular Society [CCS] III and CCS class IV angina: 30.4% vs. 26.5%; p = 0.005). They underwent percutaneous treatment more often (35.0% vs. 25.9%; p < 0.0001) and were less likely to be referred for surgery (3.7% vs. 4.9%; p = 0.0001). There were no significant differences in hospitalization outcome. New York Heart Association (NYHA) class IV for heart failure was a risk factor for both mortality and MACCE in multivariate analysis.</p><p><strong>Conclusions: </strong>The SARS-CoV-2 2019 pandemic affected the characteristics and hospitalization course of stable angina patients hospitalized following the first wave. The hospitalization outcome was similar in the analyzed time intervals. The higher prevalence of comorbidities raises concern regarding upcoming years.</p>\",\"PeriodicalId\":9492,\"journal\":{\"name\":\"Cardiology journal\",\"volume\":\"30 3\",\"pages\":\"337-343\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/61/ed/cardj-30-3-337.PMC10287081.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiology journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5603/CJ.a2022.0094\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5603/CJ.a2022.0094","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
背景:对第一波严重急性呼吸综合征冠状病毒2 (SARS- cov -2)大流行后稳定冠状动脉疾病患者的基线特征、治疗和结局的调查可能提供有价值的数据,并有利于未来几年的公共卫生策略。方法:检索2020年6月至2020年10月住院的多机构注册中心,包括10个心脏科。评估基线特征(年龄、性别、症状、合并症)、治疗(无创、有创、手术)和住院结果(死亡率、心肌梗死、卒中、复合终点-主要心脑血管不良事件[MACCE])。与2019年同一时间段(6月至10月)患者提供的参数进行比较。进行多变量分析。结果:封锁后住院的稳定患者人数较低(2498人对1903人;P < 0.0001)。他们更年轻(68.0 vs 69.0;P < 0.019),更有可能出现高血压(88.5%比77.5%;P < 0.0001),糖尿病(35.7% vs. 31.5%;P = 0.003)、高脂血症(67.9% vs. 55.4%;P < 0.0001),肥胖(35.8% vs. 31.3%;p = 0.002),以及更明显的症状(加拿大心血管学会[CCS] III级和CCS IV级心绞痛:30.4% vs. 26.5%;P = 0.005)。他们接受经皮治疗的频率更高(35.0% vs. 25.9%;P < 0.0001),且转诊手术的可能性较低(3.7% vs. 4.9%;P = 0.0001)。两组住院转归无显著差异。在多变量分析中,纽约心脏协会(NYHA)心衰IV级是死亡率和MACCE的危险因素。结论:2019年SARS-CoV-2大流行影响了第一波后住院的稳定期心绞痛患者的特征和住院时间。住院治疗结果在分析的时间间隔内相似。合并症的高患病率引起了对未来几年的关注。
The impact of first wave of the SARS-CoV-2 2019 pandemic in Poland on characteristics and outcomes of patients hospitalized due to stable coronary artery disease.
Background: An investigation of baseline characteristics, treatment, and outcomes in patients with stable coronary disease after the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS- -CoV-2) pandemic may provide valuable data and is beneficial for public health strategy in upcoming years.
Methods: A multi-institutional registry, including 10 cardiology departments, was searched for patients admitted from June 2020 to October 2020. The baseline characteristics (age, gender, symptoms, comorbidities), treatment (non-invasive, invasive, surgical), and hospitalization outcome (mortality, myocardial infarction, stroke, composite endpoint - major adverse cardiac and cerebrovascular events [MACCE]) were evaluated. The comparison was made to parameters presented by patients from the same timeframe in 2019 (June-October). Multivariable analysis was performed.
Results: Number of hospitalized stable patients following lockdown was lower (2498 vs. 1903; p < 0.0001). They were younger (68.0 vs. 69.0; p < 0.019), more likely to present with hypertension (88.5% vs. 77.5%; p < 0.0001), diabetes (35.7% vs. 31.5%; p = 0.003), hyperlipidemia (67.9% vs. 55.4%; p < 0.0001), obesity (35.8% vs. 31.3%; p = 0.002), and more pronounced symptoms (Canadian Cardiovascular Society [CCS] III and CCS class IV angina: 30.4% vs. 26.5%; p = 0.005). They underwent percutaneous treatment more often (35.0% vs. 25.9%; p < 0.0001) and were less likely to be referred for surgery (3.7% vs. 4.9%; p = 0.0001). There were no significant differences in hospitalization outcome. New York Heart Association (NYHA) class IV for heart failure was a risk factor for both mortality and MACCE in multivariate analysis.
Conclusions: The SARS-CoV-2 2019 pandemic affected the characteristics and hospitalization course of stable angina patients hospitalized following the first wave. The hospitalization outcome was similar in the analyzed time intervals. The higher prevalence of comorbidities raises concern regarding upcoming years.
期刊介绍:
Cardiology Journal is a scientific, peer-reviewed journal covering a broad spectrum of topics in cardiology. The journal has been published since 1994 and over the years it has become an internationally recognized journal of cardiological and medical community.
Cardiology Journal is the journal for practicing cardiologists, researchers, and young trainees benefiting from broad spectrum of useful educational content.